{"name":"Nuwacell Biotechnologies Co., Ltd.","slug":"nuwacell-biotechnologies-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NCR300","genericName":"NCR300","slug":"ncr300","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"NCR300","genericName":"NCR300","slug":"ncr300","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxOU3hfa0JPVU9zTXZWc1A0WkRUYVhLZlB3c1RPc1FxVU1mSFBlN0lQT0tOMHlvbXJwRlZMbFhxdV9zTkxfWXBkUFdGcWZaQkFRMHpNMWFvUGpTVjlHZzluYXp4QXI5TlJrT0NXR2JwMGFrd3hZeFdyUzVuR0NuZnVuSkEzdjRRUEFqWXhPUjhsRXBEeUFIZl9jLVc1VVoyaHRmWFRVTWw0S3pFOV9xMlYzU2RpR2ZEV1dieWpjRTd4eElFY2V6UkdhdWNOd0NUUXk1Um95SjhVNHRRRUxXNGtzc2d4a2NkcjN3YmlUWEZCWTlkc2U4YlNyMW50XzFzdw?oc=5","date":"2026-02-16","type":"trial","source":"Investing News Network","summary":"IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Investing News Network","headline":"IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-01","type":"pipeline","source":"FinancialContent","summary":"Cell & Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. - ResearchAndMarkets.com - Fi","headline":"Cell & Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Sta","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOLTNGclp3R1k1Ql95djVkdTRCRG1mbmlmSDhFTm52MlJGZjdaNG9qU1VfbWxyUUVoOWs3aUJvUUY2M3o4bEtfUExtVXNOY1F0MUU3MzRWbFRSYmZMb0V2eEJuUnNTU1cxQUVFbXZieW1TQmxXRWxuUDRtZlM2allWeUpNQlVvN0gyNHNaSE9CTjQ0TE84ZTJJT0tlSlQtX0FCQWNqMXdhMElMa1lRdDgtZDRRNU84U1otT2ZCbXdEekttb3FKSFNZbnIxRndueUw4S0d4OTR5V3BpNkV0dTNTRzVMM2oxVGxrd1p3TFZCZmNpdXIyZGJkWm1xOW83aDM0UFV2WUM3cTdWOHVrUDg2VHJqcC1YNmxmbWl4VmlhNjlKYkZHMXc?oc=5","date":"2024-11-11","type":"trial","source":"PR Newswire","summary":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeuti","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}